London, 14 August 2026 — EBM Newsdesk Analysis — By Nick Staunton
The Senate Homeland Security and Governmental Affairs Committee voted 8-5 on 6 August to hold Anthony Fauci in contempt of Congress, a week after he declined to answer more than a hundred questions at a hearing on the origins of Covid-19. The vote fell on party lines, with every Democrat opposed.
Rand Paul then did something unusual. Rather than sending the resolution to the full Senate, he referred it directly to the Justice Department the following day.
Join The European Business Briefing
New subscribers this quarter are entered into a draw to win a Rolex Submariner. Join 40,000+ founders, investors and executives who read EBM every day.
SubscribeThat shortcut is the story, and almost nobody is reporting it as such.
What Contempt Actually Means
It is worth being precise, because the term is being used loosely.
Contempt of Congress is a federal misdemeanour covering a wilful refusal to co-operate with a congressional investigation — failing to appear under subpoena, refusing to produce documents, or declining to answer questions. Congress cannot prosecute anyone. It votes a resolution and refers the matter to the executive branch, which decides whether to charge.
So Fauci has not been found to have lied. He has been found, by eight senators of one party, to have refused to answer. Those are different things, and the distinction matters for anyone writing about this.
His lawyer, David Schertler, called the vote a crude political stunt intended to punish his client for exercising a constitutional right, and described it as the continuation of a personal vendetta. Fauci used his opening statement to accuse Paul of an obsession with calling for his prosecution, and has consistently said he committed no crime.
Why Paul Skipped the Senate
The conventional route runs committee vote, then floor vote, then referral. Paul removed the middle step and said so openly, telling reporters the referral would go to the Justice Department immediately so there would be no delay.
The reason is arithmetic. A contempt resolution on the Senate floor would need 60 votes. It does not have them, and Paul acknowledged there might not be much point in holding the vote at all.
Majority leader John Thune’s response was notably unenthusiastic. Asked whether he would bring it to the floor, he said his understanding was that the chairman believed he could go directly to the Justice Department. Pressed on the legal questions, Thune said he assumed that would get tested.
That is a majority leader declining to defend his own committee chairman’s procedure. And it is the second time in a fortnight that a mechanism designed for one purpose has been repurposed for another in this case. First the pardon, which may have removed the Fifth Amendment protection it was meant to make unnecessary. Now a contempt referral routed around the chamber that would have rejected it.
The Cost of Silence
Here is where I part company with Fauci’s defenders.
He is legally entitled to invoke the Fifth. His lawyer is right that exercising a constitutional right should not be punished, and his caution is understandable given that anything said now falls outside the January 2025 pardon and would be freshly prosecutable.
But he ran the National Institute of Allergy and Infectious Diseases for 38 years, directing billions in public research funding and, for two years, much of the American pandemic response. Declining to answer more than a hundred questions about that work is a defensible legal strategy and a considerable public cost.
Every unanswered question becomes an answer in someone else’s mouth. The vacuum has been filled, comprehensively, and not by people interested in the distinction between refusing to testify and being guilty of something. Silence protected the individual and damaged the institution he spent his career building.
That is not a legal criticism. It is an institutional one, and it is the part that should concern anyone who wants public health bodies to be believed the next time.
Why This Matters in Europe
Because the same erosion is under way here with less drama and no hearings.
European regulators are currently asking a great deal of business on trust: the AI Act, NIS2, CSRD, the packaging regulation. All require companies to accept that the body writing the rules is competent and honest. That assumption has been weakening for years, and the mechanism is the same one visible in Washington — institutions that resist disclosure until compelled, then wonder why the eventual explanation is not believed.
The European Commission spent two years refusing to release Ursula von der Leyen’s text messages with Pfizer’s chief executive before a court found its reasoning inadequate. The National Institutes of Health fought royalty disclosure through two federal lawsuits and lost. In both cases the underlying conduct was probably defensible. The resistance is what did the damage.
It is the same argument for stronger audit trails and for treating disclosure as a governance discipline rather than a legal chore. And it applies to institutions Europeans assume are neutral, as the Bank of England is finding over Venezuela’s gold.
My Read
My view is that both sides of this have chosen the tactic that wins the week and loses the decade.
Paul has a real oversight case. Gain-of-function funding, the shift in the intelligence assessment towards a laboratory origin, and the gap between what was said publicly and considered privately are all legitimate subjects for a Senate committee. But he has pursued them through a partisan committee vote and a procedural manoeuvre his own majority leader will not endorse, which guarantees the findings are read as politics rather than oversight. If the aim was accountability, the method has undermined it.
Fauci has a real legal argument and is using it in a way that will define his reputation more than anything he did in office. Forty years of AIDS research and the architecture of PEPFAR are now filed behind a fortnight of refusals.
The Justice Department will now decide whether to charge a misdemeanour referred to it by half a Senate committee. My expectation is that it does nothing, that Paul says so loudly, and that neither the origins of the pandemic nor the conduct of the response gets any closer to a settled account.
Meanwhile the thing that actually needed protecting — public willingness to believe a health agency in the next emergency — has taken more damage in a fortnight than in the two years of argument that preceded it.
Related Analysis
